Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. BASF SE
EIR
•BASF SE•March 17, 2010

BASF SE – FDA EIR, Mar 17, 2010

Record Details

An FDA inspection of BASF SE, an Active Pharmaceutical Ingredient (API) manufacturer located in Ludwigshafen Am Rhein, Germany, was conducted from March 15 to March 17, 2010. This comprehensive pre-approval and Good Manufacturing Practice (GMP) inspection was performed in accordance with FDA compliance programs for drug process inspections, specifically targeting API manufacturing and pre-approval assessments, utilizing ICH Q7A guidelines as a guide. The inspection covered various systems including Quality, Production, Facilities & Equipment, Materials, Packaging & Labeling, and Laboratory operations.

The inspection resulted in two observations documented on Form FDA 483. The first deficiency noted inadequate corrective actions for a previously identified process deviation. The second observation concerned incomplete information within the company's reprocessing Standard Operating Procedure (SOP). Company management acknowledged these findings, agreeing to implement prompt corrections. The FDA classified this inspection as "Voluntary Action Indicated" (VAI), signifying that although objectionable conditions were found, they do not warrant immediate administrative or regulatory action. A re-inspection is scheduled for March 2012 to verify the adequacy of the implemented corrective actions.

Company
BASF SE
Inspection date
March 17, 2010
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • James C. Maclaughlin (investigator)
  • Mel Szymanski (issuing_officer)
  • Cesar E. Matto (Senior Policy Advisor)
View Company Profile

ID · c5f29c33-7620-43c4-8738-516f12311f28

Other documents for BASF SE
  • EIR - 2018-07-13July 13, 2018
  • EIR - 2016-03-10March 10, 2016
  • EIR - 2013-07-30July 30, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BASF SE
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.